ABSTRACT Seven monoclonal antibodies against mouse B 16 melanoma cells (produced in syngeneic C57BL/6 mice) were selected that blocked the adhesion of melanoma cells to tissue culture dishes. These antibodies were found to be directed against antigens on the surface of mouse B 16 melanoma cells but not on normal mouse cells such as 3T3 fibroblasts. Similarly, the antigens could not be detected in normal mouse tissues (e.g., lung, kidney, liver) but were found in lungs colonized by B 16 melanoma cells. Significantly, three of these antibodies virtually abolished lung colonization of highly invasive B 16 sublines injected into the animals' bloodstream. They exerted their effect both when preabsorbed by the melanoma cell in vitro and when delivered to the animals prior to the tumor cells. It is suggested that monoclonal antibodies might be a promising tool for preventing metastasis.
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Metastasis represents a crucial and complex event in cancerogenesis. It can be separated into several distinct steps: detachment of some transformed cells from the primary tumor, their migration in the host's bloodstream, adhesion of these migratory cells to vascular endothelia at some distant sites, and their penetration and growth in the stroma at the new areas (1) (2) (3) . The mouse B 16 melanoma has frequently been used in order to examine the second part-i.e., adhesion, penetration, and growth-of this pathway (2) (3) (4) . Experimentally, when B 16 cells are injected into the tail veins of syngeneic C57BL/6 mice, dark metastatic lesions in the lungs, brain, and other organs can be detected [10] [11] [12] [13] [14] [15] [16] [17] [18] [19] [20] days later (3, 5, 6) .
From the original low-metastatic B 16-F 1 cell population, highly metastatic variants have been isolated mainly by two procedures: (i) multiple passage through the lungs and other organs in vivo [e.g., B 16-F 10; such lines are quite stable (5-7)] and (ii) subcloning of B 16-F 1 under limiting-dilution conditions [these lines are somewhat unstable (8, 9) ]. It furthermore has been suggested that the differences between such lines might be expressed on their plasma membrane, because the potential for a higher rate of metastasis was transferable to lowmetastatic sublines (F 10 to F 1) through fusion with membrane vesicles (10) .
The basis of the present work was the idea that, because the attachment of free-floating melanoma cells in the host's bloodstream is a critical event in metastasis, one might be able to suppress this step by use of monoclonal antibodies directed against particular surface antigens. Furthermore, similar surface antigens might also be involved in the adhesion of melanoma cells under certain in vitro conditions, and this would permit an easier selection of promising hybridomas. Our laboratory has previously produced a series of monoclonal antibodies that prevented the adhesion of various cell types to tissue culture dishes (11) . In immunofluorescence studies, one of these antibodies (anti-FC-1) stained the focal contacts of the cells, organelles known to be involved in the adhesion process (11) . With this antibody, we have identifed a new membrane surface molecule (Mr, 60,000) which, in vivo, is enriched at cellsubstrate interphases of various epithelial monolayers.
In the present investigation we immunized C57BL/6 mice with syngeneic B 16-F 1 melanoma cells and selected seven monoclonal antibodies that prevented the adhesion-of melanoma but not other mouse cells in vitro. We report here on the effect of these antibodies on metastasis in vivo.
MATERIALS AND METHODS Immunization. C57BL/6 mice (obtained from Zentralinstitut fur Versuchstierzucht, Hannover, Federal Republic of Germany) were immunized with 5 x 106 B 16-F 1 melanoma cells (generous gifts of M. Wabl and R. Kemler, Tfibingen) that had been scraped from tissue culture dishes and irradiated with 3,500 R (1 R = 2.58 X 10-4 C/kg). The first injections were in complete Freund adjuvant; the following ones were in incomplete adjuvant (for further details and the fusion protocol, see ref. 12 ).
In Vitro Attachment Assay. Subconfluent B 16 melanoma cells were treated with trypsin/EDTA for 1 min, the reaction was stopped with excess medium containing 10% serum, and the cells were centrifuged at 200 x g. Between 500 and 1,000 cells were then plated in 50-100 jud of hybridoma supernatant or in corresponding control medium (from NS-1 myeloma cells) on tissue culture dishes. The plates were incubated at 370C in 10% C02/90% air for the times indicated, then carefully washed with phosphate-buffered saline. The attached cells were fixed with 3% formaldehyde, and the whole area was examined in a reverse microscope (see also ref. 11).
Assay for Metastasis. Gently trypsinized cells (106) of the highly metastatic sublines C 11, C 15, and B 16-F 10 were incubated for 1 hr on ice with 5 ml of the different hybridoma supernatants or with control medium. Cells were then centrifuged and suspended in phosphate-buffered saline, and 1 or 2 x 105 living cells were injected into the tail veins of C57BL/ 6 mice. The animals used for these experiments were sexmatched and always 6-10 weeks old. The lungs of the injected mice were examined for black colonies which were visible on the surface after 10-12 days.
Monoclonal antibodies (as ascites fluids obtained from BALB/ c X C57BL/6 mice) were injected intraperitoneally into C57BL/ 6 mice. Highly metastatic melanoma cells were then delivered intravenously as described above.
Adsorption. The publication costs of this article were defrayed in part by page charge payment. This article must therefore be hereby marked "advertisement" in accordance with 18 U.S.C. §1734 solely to indicate this fact. Table 2 ) and hybridoma supernatant 16/43 as antibody (see Table 1 ). Similar kinetics of inhibition was seen with the other monoclonal antibodies.
gently disrupting them on a tissue sieve (Bellco Glass) to a single-cell suspension. After adsorption the cells were centrifuged and the supernatants were tested for residual activity in the attachment assay with B 16-C 11 melanoma cells as described above. RESULTS and guinea pig complement (14) (Fig. 2A) . Furthermore, the antibodies were not significantly adsorbed by cells isolated from kidney, liver, and lung tissue of C57BL/6 mice but did react with cells from a lung colonized with B 16 melanoma (Fig. 2B) amined their potential to grow in agar (14) and their ability to form metastatic lesions in lungs of C57BL/6 mice ( Table 2) . Four of them (C 1, C 11, C 15, and C 18) showed a significantly higher metastatic potential in comparison to the original B 16-F 1 population (=10 metastatic lesions per lung). Two of the subclones (C 11 and C 15) formed more than 300 metastatic lesions after injection of 2 x 105 cells per animal. The more highly metastatic clones were all found to be of the fibroblastic type. There was no strong correlation between the growth of the different subclones in agar and their capability to form metastatic lesions in lung in vivo (cf. ref. 14) .
In a further series of experiments we examined the in vitro effect of our anti-B 16 monoclonal antibodies upon the newly isolated B 16 subclones with high metastatic potential. As with B 16-F 1, all antibodies reduced cell-substrate adhesion of clones C 11 and C 15 (Table 3) . Similarly, attachment to culture dishes was inhibited in the case of B 16-F 10, a cell line of high metastatic potential derived from F 1 by 10-fold passage through the lungs of C57BL/6 mice. In vitro, antibodies 16/82, 16/43, 16/77, and 16/81 were the most effective. The antibodies were not cytotoxic as determined in a cytotoxicity assay with rabbit were then injected into the tail veins of C57BL/6 mice, and the lungs of the animals were examined for metastatic lesions after 12 days. The data are means from four and two animals in Exps. 1 and 2-4, respectively. * In all experiments, other organs such as brain, liver, testis, and spleen were also screened for metastasis but were always found to be negative.
cular endothelia of target tissues is a prerequisite for the generation of metastatic lesions. Therefore, we examined whether the monoclonal antibodies that inhibited cell attachment in vitro would also effect adhesion in vivo. C 11 and C 15, the two highly metastatic sublines of B 16-F 1, and B 16-F 10 were incubated with a saturating amount of the noncytotoxic antibodies described above and then injected into C57BL/6 mice. The melanoma cells that were exposed to antibodies 16/82, 16/43, and 16/77 showed a significant reduction (down to 5-20%) in the formation of lung colonies (Table 4 ; Fig. 3 ). The other four anti-B 16 antibodies (19/1, 16/56, 16/51, and 16/81) as well as the anti-CEF antibodies had no effect. C57BL/6 mice were preinjected with ascites fluid from different hybridomas, and the potential for lung colonization by B 16 subline C 11 was then examined. Again, the number of lung nodules was significantly reduced in the case of the antibodies 16/43, 16/77, and 16/82 (Table 5 ). The anti-CEF (e.g., 2/92) and other anti-B 16 antibodies (e.g., 19/1) at the same concentrations had no effect. DISCUSSION B 16 melanoma proved to be a suitable experimental system for study of mechanisms involved in the generation of metastatic a .
:~.,. . lesions because (i) syngeneic mice (C57BL/6) are available as inbred strains, (ii) the formation of metastatic lesions in the lungs and other organs is rapid and highly reproducible, and (iii) the metastatic lesions are easily recognized as dark nodules (2, 3) .
In the present work we produced, by syngeneic immunization, a series of monoclonal antibodies that prevented the adhesion of B 16 melanoma cells to artificial substrates in vitro. Three of these antibodies also drastically reduced the formation of lung colonies, most likely by interfering with the initial arrest of the tumor cells at the vascular endothelia of the lungs (Tables 4 and  5 ; Fig. 3 ). The procedure of syngeneic immunization has been used in analogous systems by other investigators: e.g., antibodies exclusively directed against the 60,000-dalton src gene product were obtained through immunization of BALB/c mice with Rous sarcoma-transformed BALB/c 3T3 cells (16) , and monospecific antisera could be raised in rats and mice against tumor cells (15, 17) . Similarly, if we consider B 16 melanoma cells as tumorigenic mutants of C57BL/6 melanocytes, syngeneic immunization likely leads to antibodies against possible tumor-associated antigens. Indeed, the seven anti-B' 16 monoclonal antibodies reacted with B 16 melanoma when tested in cell adhesion assays and showed crossreaction with embryonal but not with differentiated mouse cells (Table 2) . Furthermore, the three antibodies examined more closely in adsorption experiments did not crossreact with normal mouse cells or with cells from four In vitro, the anti-B 16 antibodies were found to be most active within the first hours (Fig. 1) 
